LORATADINE
- Product NDC
- 51316-503
- Requested package NDC
- 51316-503-06
- 11-digit product format
- 513160503
- Labeler code
- 51316
- Product ID
- 51316-503_0df114fa-ae43-e77d-e063-6294a90a8c36
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- LORATADINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- CVS PHARMACY, INC
- Application
- ANDA213294
- Marketing category
- ANDA
- Marketing start
- 2021-08-08
- Substance
- LORATADINE
- Active strength
- 10 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213294-001 | LORATADINE | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 8869cabd3fbd… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213294-001 | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-10-30 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LORATADINE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LORATADINE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7AJO3BO7QN | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 311373 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7ed2aec0-4da7-4edc-9998-b96c67c82738 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 51316-503-01 | 2023-02-09 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-02 | 2023-02-09 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-03 | 2023-02-09 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-04 | 2023-02-09 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-05 | 2023-02-09 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-06 | 2023-02-09 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-01 | 2023-01-30 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-02 | 2023-01-30 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-03 | 2023-01-30 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-04 | 2023-01-30 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-05 | 2023-01-30 | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-06 | 2023-01-30 | Loratidine Orally Disintegrating Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51316-503-01 | LORATADINE | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 8 | |
| 51316-503-01 | LORATADINE | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 8 | |
| 51316-503-02 | LORATADINE | 20 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 20 | 8 | |
| 51316-503-02 | LORATADINE | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | 8 | |
| 51316-503-03 | LORATADINE | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 8 | |
| 51316-503-03 | LORATADINE | 30 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 30 | 8 | |
| 51316-503-04 | LORATADINE | 40 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 40 | 8 | |
| 51316-503-04 | LORATADINE | 4 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 4 | 8 | |
| 51316-503-05 | LORATADINE | 50 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 50 | 8 | |
| 51316-503-05 | LORATADINE | 5 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 5 | 8 | |
| 51316-503-06 | LORATADINE | 6 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 6 | 8 | |
| 51316-503-06 | LORATADINE | 60 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 60 | 8 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allervarx | LORATADINE | Innovus Pharmaceuticals, Inc. | 885e81ae-5ea3-4d14-8666-8c2698767014 | 2024-12-27 | Warnings | 213294 ANDA213294 |
| Alavert Allergy | LORATADINE | Foundation Consumer Healthcare | 1704474a-9b99-de45-e063-6294a90ac59b | 2024-06-24 | Warnings | 213294 ANDA213294 |
| LORATADINE | LORATADINE | Tenshi Kaizen Pvt Ltd | 9c168fbb-6668-4a9d-9c7e-d3441e60eb95 | 2024-05-07 | Warnings | 213294 ANDA213294 |
| Alavert Allergy | LORATADINE | Foundation Consumer Healthcare | 15c3f848-fef6-433b-e063-6394a90abd2b | 2024-05-01 | Warnings | 213294 ANDA213294 |
| LORATADINE | LORATADINE | CVS PHARMACY, INC | 7ed2aec0-4da7-4edc-9998-b96c67c82738 | 2024-01-02 | Warnings | 213294 ANDA213294 51316-503-06 51316-503 51316050306 |
| LORATADINE | LORATADINE | Strides Pharma Inc | 16ab6610-ac99-4714-848d-9377c6bca459 | 2024-01-02 | Warnings | 213294 ANDA213294 |
| LORATADINE | LORATADINE | Tenshi Kaizen Pvt Ltd | c20b916d-7dd0-1a56-e053-2995a90a3c1b | 2024-01-02 | Warnings | 213294 ANDA213294 |
| LORATADINE | LORATADINE | Dr. Reddy's Laboratories Inc. | d707733d-1ee9-92d3-f5b2-3567b9c217c2 | 2023-06-25 | Warnings | 213294 ANDA213294 |
| LORATADINE | LORATADINE | Dr. Reddy's Laboratories Inc. | bb6af6a4-aec0-ddf5-57b7-063504ca8e1e | 2023-06-25 | Warnings | 213294 ANDA213294 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311373 | loratadine 10 MG 24HR Disintegrating Oral Tablet | PSN | 7ed2aec0-4da7-4edc-9998-b96c67c82738 | 8 |
| 311373 | loratadine 10 MG Disintegrating Oral Tablet | SCD | 7ed2aec0-4da7-4edc-9998-b96c67c82738 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51316-503-06 | 51316050306 | 6 BLISTER PACK in 1 CARTON (51316-503-06) / 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 6 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |